Practical Neurology

10/31/2025

October is ! In a podcast episode, film producer and director AJ Tesler shared the story of his daughter, Magnolia, who is living with syndrome. In case you missed it, listen today:
https://ow.ly/Aoh250Xletx
International Rett Syndrome Foundation American Epilepsy Society

AJ Tesler shares the story of his daughter, Magnolia, who is living with Rett syndrome. As a parent and caregiver, AJ provides his perspective throughout …

10/30/2025

In care, community health workers can serve as care extenders for screening, coordination, & management. Read a new Horizons column article by Drs. Begasse de Dhaem, Logan, Galdo, & Starling.
https://ow.ly/A2b550XcO6p
American Headache Society® American Migraine Foundation American Academy of Neurology (AAN) Mayo Clinic CPESN

10/29/2025

The U.S. Food and Drug Administration has granted fast track designation to an investigational treatment for people with treatment.
https://ow.ly/EcTf50XjXGJ
Kennedy's Disease Association Muscular Dystrophy Association American Academy of Neurology (AAN) American College of Physicians (ACP) Child Neurology Society

The Food and Drug Administration (FDA) has granted Fast Track designation to AJ201 (AnnJi Pharmaceutical Company, Taipei City, Taiwan) for investigation a…

10/29/2025

The U.S. Food and Drug Administration has cleared the CTA tool for use in the AI-based, automated detection of large vessel occlusions from CT angiography images.
https://ow.ly/Uil550XjpM7
American Heart Association Endovascular Today Stroke Association American Stroke Association

The Food and Drug Administration has granted 510(k) clearance to Methinks CT Angiography (CTA) Stroke (Methinks Software, Barcelona, Spain), an artificial…

10/27/2025

Higher intake of artificial sweeteners—like aspartame, saccharin, sorbitol, and more—was linked to faster cognitive decline among adults

Higher consumption of low- and no-calorie sweeteners (LNCSs) was associated with accelerated cognitive decline, particularly in verbal fluency and global …

10/27/2025

In this month's issue, Drs. Hedeman, Herrema, & Gilbert review strategies for managing symptoms of 's: , , , & effect. https://ow.ly/6Km550XhkNS
Trinity Health MI American Psychiatric Association American Academy of Neurology (AAN) International Parkinson and Movement Disorder Society

Anxiety, panic, depression, apathy, and pseudobulbar affect, require careful assessment and various treatment options to improve quality of life.

10/26/2025

Findings published in Neurological Sciences demonstrate the efficacy of a novel practical prognostic model for acute .
https://ow.ly/6Rqb50Xhb25
Endovascular Today American Heart Association National Institutes of Health (NIH)

Findings published in Neurological Sciences demonstrate the efficacy of a novel practical prognostic model for acute ischemic stroke, which integrates vas…

10/24/2025

How can be optimally used in the operating room? William O. Tatum, DO—Epilepsy Essentials Column Editor—and Brin E. Freund, MD discuss practical applications as technology evolves. https://ow.ly/Cr7o50XcNSc
Mayo Clinic Mayo Clinic Neurology and Neurosurgery American Epilepsy Society Epilepsy Foundation of America

Intraoperative EEG monitoring of brain function during surgical procedures acquires real-time electrophysiologic signals and provides immediate feedback.

10/24/2025

New in Nature Communications: Targeted thalamic stimulation reduced epileptiform activity in drug-resistant focal .
https://ow.ly/BJct50XhaQ3
American Epilepsy Society American Academy of Neurology (AAN) Epilepsy Foundation of America American Association of Neurological Surgeons

Study results published in Nature Communications demonstrated a reduction in cortical interictal epileptiform discharge (IED) and seizure frequency in ind…

10/23/2025

clearance after ( ) treatment was associated with slower clinical decline in people with 's, according to research published in JAMA Neurology.
https://ow.ly/xeXW50Xhfmi
Eli Lilly and Company Alzheimer's Association American Academy of Neurology (AAN)

A secondary analysis of results from the TRAILBLAZER-ALZ 2 phase 3 trial (NCT04437511) published in JAMA Neurology demonstrated an association between low…